Detection of FIP1L1-PDGFRA fusion by FISH
Multisystem Erdheim-Chester disease; a unique presentation with liver and axial skeletal involvement
Dendritic cells and myeloid leukaemias
Modern treatment of thalassaemia intermedia
Inhibitor development in haemophilia B
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas
Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
Activation of Wnt/β-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia
Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals1
Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation
Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency
Thrombin generation
Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02)
Expression of the γ-globin gene is sustained by the cAMP-dependent pathway in β-thalassaemia
Unexpected cardiotoxicity in haematological bortezomib treated patients
Hemizygous antithrombin-deficiency (Budapest III) in a newborn presenting with a thrombosis at birth
Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes
Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism
Corrigendum